[ad_1]
The EU’s medicines regulator, the European Medicines Agency (EMA), said on Thursday it had given the green light to two vaccines that target the omicron variant of Covid-19, AFP reported. They were developed by US-German BioNTech-Pfizer and by US company Moderna, both of which created vaccines against the original strain of the virus. They function as boosters for people who have already had a full dose of the original vaccine.
Read and decide
Get instant access to all articles — and 20 years of archives.
Join EUobserver today
Become an expert on Europe
Get instant access to all articles — and 20 years of archives.
14-day free trial.
… or subscribe as a group
[ad_2]
Source link